Phenibut & MAOI
Phenibut is a central nervous system (CNS) depressant that is used as an anxiolytic and nootropic agent. It is a synthetic derivative of the neurotransmitter gamma-aminobutyric acid (GABA).
Phenibut works by binding to GABA receptors in the brain and enhancing the activity of GABA, which can produce a calming and sedative effect. It primarily acts as an agonist at the GABA-B receptors and, to a lesser extent, at the GABA-A receptors. This can help to reduce anxiety and promote relaxation, and it may also improve sleep quality and cognitive function.
In addition to its effects on GABA receptors, phenibut has also been shown to have an affinity for dopamine receptors, which may contribute to its nootropic effects. However, the exact mechanisms of action of phenibut are not well understood, and further research is needed to fully understand how it works.
Monoamine oxidase inhibitors (MAOIs) are drugs mainly used to treat depression and other mental health conditions by inhibiting the activity of monoamine oxidase (MAO), an enzyme responsible for breaking down neurotransmitters in the brain, such as dopamine, norepinephrine, and serotonin.
There are two types of MAO in the brain: MAO-A and MAO-B, and MAOIs can target one or both of these enzymes. MAO-A breaks down serotonin and norepinephrine, while MAO-B breaks down dopamine. Some MAOIs target both MAO-A and MAO-B, while others target only one of them.
There are more two types of MAOIs: irreversible and reversible.
- Irreversible MAOIs, such as phenelzine (Nardil) and tranylcypromine (Parnate), work by irreversibly binding to the enzyme monoamine oxidase, which is responsible for breaking down neurotransmitters. This results in an increase in the levels of neurotransmitters, which can improve mood and reduce symptoms of depression.
- Reversible MAOIs, such as moclobemide (Manerix), work by binding to the enzyme monoamine oxidase for a shorter period and with less affinity than irreversible MAOIs. This allows the enzyme to resume its normal activity more quickly, which reduces the risk of side effects.
The interactions between Phenibut and MAOIs are not well understood, but the combination may lead to unpredictable conditions. While there is no reliable data on negative interactions between Phenibut and MAOIs, there are potential risks and side effects when combining these substances:
Increased sedation and CNS depression: Since both Phenibut and MAOIs have sedative effects, their combination can lead to an increase in central nervous system (CNS) depression. This may result in excessive drowsiness, impaired motor coordination, and cognitive impairment. In severe cases, it can lead to respiratory depression and coma.
Indirect serotonin syndrome: Although Phenibut's primary action is on the GABAergic system, it may also have an indirect effect on the serotonergic system. When combined with an MAOI, which increases the levels of serotonin in the brain, there is a risk of developing serotonin syndrome. This is a potentially life-threatening condition characterized by symptoms such as agitation, confusion, rapid heart rate, high blood pressure, muscle rigidity, and fever.
A general increase in the risks of side effects due to the multimodal action of Phenibut and the ability to potentiate the effects of other substances. Some of the potential side effects of combining Phenibut and MAOIs also include nausea, vomiting, headache, irregular heartbeat, and seizures. In severe cases, this combination can also lead to loss of consciousness, collapse, and coma.
Some drugs from the group of irreversible selective MAO-B inhibitors are antiparkinsonian agents (Selegilinum, Befol). Phenibut has the ability to lengthen and enhance the effect of substances from this class. This property can be used in treatment, but requires a reduction in starting dosages and careful monitoring of the condition.
Also, this combination does not reveal any effects and actions of a recreational nature and theoretically may be of interest only to people undergoing course treatment with one of the indicated drugs.
Considering the above, we recommend treating this combination with great caution.
Last edited by a moderator: